November 12, 2018
Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 12, 2018--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L.
Washington, Gilead’s Executive Vice President and Chief Financial
Officer, and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer
and Head of Research & Development, will participate in a fireside chat
at the Evercore ISI HealthCONx Conference in Boston on Tuesday, November
27 at 9:30 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live through
the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be required to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that
discovers, develops and commercializes innovative medicines in areas of
unmet medical need. The company strives to transform and simplify care
for people with life-threatening illnesses around the world. Gilead has
operations in more than 35 countries worldwide, with headquarters in
Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181112005782/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792